Defining Virologic Relapse in Chronic Hepatitis B
Kyung‐Hee Kim(Kookmin University), Seung Woon Paik(National Cancer Center), Kwang Cheol Koh(Samsung Medical Center), Won Kyoung Yun(Samsung Medical Center), Joon Hyeok Lee(Samsung Medical Center), Geum‐Youn Gwak(Samsung Medical Center), Moon Seok Choi(Samsung Medical Center), Dong Hyun Sinn(Samsung (South Korea)), Yun Young Lee(Chonnam National University), Byung Chul Yoo(Konkuk University), Hyun Chin Cho(Gyeongsang National University Hospital)
Cited by 4
Related Papers
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Genome and evolution of the shade‐requiring medicinal herb <i>Panax ginseng</i>
|Plant Biotechnology Journal|2018|224
Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 3
|Journal of Viral Hepatitis|2015|159